Acutus is rolling out the AcQCross Qx left-heart access system for use with Boston Scientific’s TruSeal and FXD delivery systems for its Watchman left-atrial appendage closure devices.
Minute Insight: Acutus Adds Another Device To The Left-Heart Business It Sold To Medtronic
The company announced the US launch of the AcQCross Qx transseptal dilator/needle. It is specifically designed to help deploy Boston Scientific’s Watchman left-atrial appendage closure device, but it is part of the left-heart access device portfolio that Acutus recently sold to Medtronic.
